TY  - CHAP
M1  - Book, Section
TI  - Increased Platelet Destruction
A1  - Leavitt, Andrew D.
A1  - Price, Erika Leemann
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
Y1  - 2022
N1  - 
T2  - Current Medical Diagnosis & Treatment 2022
AB  - KEY  CLINICAL  UPDATES  IN  INCREASED  PLATELET  DESTRUCTIONThe  role  of  caplacizumab  in  the  treatment  of  thrombotic  thrombocytopenic  purpura  remains  controversial  given  its  high  cost  and  limited  benefit,  despite  its  inclusion  in  2020  guidelines.Careful  monitoring  of  the  ADAMTS-13  activity  and  inhibitor  status  and  use  of  rituximab  can  prevent  dangerous  relapses.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1184168526
ER  -